Sikiric et al., 2011
Studies have shown that GLP-1 treatment significantly increases the expression levels of BTG2, Pdx1, and the insulin gene in pancreatic cells, indicating that GLP-1 positively regulates insulin gene expression through BTG2, thereby promoting insulin synthesis (Hwang et al., 2013)
Read more in our anti-inflammatory diet guide which includes vegan adaptations
In July 2025, Eli Lilly and Company announced topline results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase III cardiovascular outcomes trial comparing two incretin therapies in adults with type 2 diabetes and established atherosclerotic cardiovascular disease
We now have multiple years of additional data, expanded FDA approvals, and a much clearer understanding that GLP-1 medications affect not only metabolism, but also the brain, behavior, and emotional experience
Grigorev, A.E